A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Prince of Wales Hospital, Sydney

Royal North Shore Hospital, Saint Leonards

Royal Melbourne Hospital, Parkville

Mercy Hospital for Women, Heidelberg

Royal Brisbane & Women's Hospital, Herston

Flinders Cancer Clinic - Flinders Medical Centre (FMC), Bedford Park

Charles Gairdner Hospital, Nedlands

Hospital Vall d'Hebron, Barcelona

New York University Langone Medical Center, New York

Memorial Sloan-Kettering Cancer Center, New York

Women's Cancer Care Associates, Albany

UPMC Cancer Center, Pittsburgh

University of Pennsylvania, Philadelphia

Fox Chase Cancer Center, Philadelphia

Johns Hopkins Kimmel Cancer Center, Baltimore

Hope - A Woman's Cancer Institute, Asheville

Institut Claudius Regaud, Toulouse

Mayo Clinic Jacksonville, Jacksonville

Florida Hospital Cancer Institute, Orlando

UF Health Cancer Center, Orlando

Institut Bergonie, Bordeaux

University of Miami Hospital & Clinics Sylvester Comprehensive Cancer Center, Miami

Altus Research, Lake Worth

Norton Cancer Institute, Louisville

The Ohio State University Wexner Medical Center, Columbus

Centre Catherine de Sienne, Nantes

University of Cincinnati Physicians Company, Cincinnati

Instituto Valencia de Oncologia, Valencia

Hospital Clinico Universitario de Valencia, Valencia

Horizon BioAdvance, Lafayette

Mayo Clinic, Rochester

Washington University School of Medicine, St Louis

Centre Leon Berard, Lyon

Centre Hospitalier Lyon Sud, Pierre-Bénite

University of Oklahoma, Oklahoma City

Hopital Tenon, Paris

Hôpital Européen Georges-Pompidou, Paris

The University of Texas MD Anderson Cancer Center, Houston

Rocky Mountain Cancer Centers, Lakewood

University of Arizona Cancer Center, Tucson

Comprehensive Cancer Centers of Nevada, Henderson

University of California Los Angeles, Los Angeles

UC San Diego, San Diego

Saint Jude Heritage Medical Center, Fullerton

Coastal Integrative Cancer Care, San Luis Obispo

Central Coast Medical Oncology, Santa Maria

California Pacific Medical Center, San Francisco

University of California, San Francisco, San Francisco

Stanford University, Stanford

Institut de cancerologie Gustave Roussy, Villejuif

University of Washington - Seattle Cancer Care Alliance, Seattle

Providence Alaska Medical Center, Anchorage

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston

Crown Princess Mary Cancer Centre (Westmead Hospital), Westmead

Tom Baker Cancer Centre, Calgary

Cross Cancer Centre, Edmonton

British Columbia Cancer Agency, Kelowna

BC Cancer Agency - Fraser Valley Centre, Surrey

Vancouver Cancer Centre, British Columbia Cancer Agency (BCCA), Vancouver

London Regional Cancer Centre, London

Ottawa Hospital Cancer Centre, Ottawa

Princess Margaret Cancer Centre, Toronto

Centre Hospitalier de L'Universite de Montreal, Montreal

Jewish General Hospital, Montreal

CHU de Québec - Université Laval, Québec

Beatson West of Scotland Cancer Centre, Glasgow

Royal Marsden Sutton Hospital, Sutton

St James University Hospital, Leeds

Addenbrooke's Hospital, Cambridge

Royal Marsden NHS Foundation Trust, London

Imperial College Healthcare NHS Trust - Hammersmith Hospital, London

University College London, London

The Christie NHS Foundation Trust, Manchester

Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Newcastle upon Tyne